IL-HALLSTAR
Hallstar, a specialty chemical company based in Chicago, has been awarded the 2017 Global in-cosmetics® Innovation Silver Prize for its revolutionary new anti-aging ingredient, Micah. Winners were announced at the in-cosmetics® conference in London on April 4th. The awards are given to honor the development of a novel active or functional ingredient combining innovative science and product features in a way that demonstrates substantial benefits to manufacturers and end-users.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170413005838/en/
“I’m delighted to see our R&D team receive this prestigious recognition,” said John Paro, Hallstar’s Chairman, President and CEO. “We are committed to innovation and to providing the right chemistry so our customers can work wonders with their products. Micah is a great example of Hallstar’s world-class capabilities.”
in-cosmetics® attracts a global audience of cosmetic manufacturers, distributors and consultants, and is the leading innovation launch pad for the personal care industry. Around 100 Innovation Award entries from around the world were received for the 2017 prize.
“Micah’s breakthrough chemistry represents a whole new category of sun care protection and anti-aging because it halts the photo-aging process before it starts,” explained Robert Hu, Vice President of Research & Development. “Independent clinical research shows that Micah, unlike sunscreens or antioxidants, prevents 100% of free radicals, ROS, inflammation, and DNA damage from UVA and Visible Light, at a use level of only 0.2%.”
Varun Mathur, Hallstar’s Beauty & Personal Care General Manager, was on-hand in London to accept the award. “Hearing Hallstar announced from the stage affirmed our confidence in Micah’s potential. Whether it be a serum, sunscreen or moisturizer, Micah could be an integral part of any anti-aging solution."
To learn more, download the brochure , read the Hallstar whitepaper, “Stopping the Clock: Understanding Micah Chemistry ,” or contact Dennis Zlotnik at dzlotnik@hallstar.com .
About Hallstar:
Hallstar is a leading global provider of specialty chemistry solutions. The company takes a collaborative approach to every engagement, delivering technical support, chemistry expertise and industry knowledge that helps its customers make the most of their products, from concepts to the first production batches. Visit www.hallstar.com to learn more.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170413005838/en/
Contact:
Marie Paro
Hallstar
mparo@hallstar.com
312-554-7470
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CSG and NetLync Drive MNO and MVNO eSIM Transformation29.4.2025 09:30:00 CEST | Press release
Launch next-generation Entitlement SaaS platform that helps operators accelerate eSIM-only innovation and navigate the rapidly evolving telecom landscape With eSIM set to become the standard for all new phones this year,mobile network operators (MNOs) and mobile virtual network operators (MVNOs) face mounting pressure to modernize their entitlement infrastructure. To address this market need, CSG® (NASDAQ: CSGS) today announced a new partnership with leading entitlement server provider NetLync and launched CSG Entitlements-as-a-Service, powered by NetLync. This new SaaS platform gives operators the speed and agility they need to power seamless iOS and Android experiences in weeks, not months. It helps them stay competitive in an eSIM-only future and avoid the high costs of building and managing their own entitlement infrastructure. “The shift to eSIM-only devices drives a major change in the telecommunications industry that will redefine user experiences,” said Chad Dunavant, Chief Pro
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital29.4.2025 09:29:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public letter to shareholders in response to hostile actions and false claims by Vivo Capital and certain other parties (the “Vivo group”) against the legitimate and lawful actions of the Board. Dear Shareholders, We are writing to set the record straight in response to the Vivo group’s recent press releases, lawsuits and other actions against SINOVAC and the Board, particularly those related to the Board’s decision to declare a cash dividend of US$55.00 per common share to SINOVAC shareholders. The Vivo group is now attempting to block the special dividend payments to you via lawsuits and by sending threatening letters and messages to the Company’s stock transfer agent and board members. It is particularly concerning that the Vivo group is trying to prevent all SINOVAC common shareholders (who hav
Suzano 2024 Annual Report on Form 20-F29.4.2025 09:29:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2024 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20250429838200/en/
KRAFTON Achieves Record-High Quarterly Sales in Q1 202529.4.2025 09:00:00 CEST | Press release
Thanks to PUBG IP expansion, inZOI’s strong debut, and BGMI’s global growth, quarter-over-quarter sales are up 41.6%, while operating profit is up 112.2% KRAFTON, Inc. today announced its first quarter earnings results for 2025. Based on consolidated financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS), the company achieved a record-high quarterly sales performance of 874.2B KRW and operating profit of 457.3B KRW. In addition to high quarter-over-quarter growth, year-over-year growth has also set records with sales up by 31.3% and operating profit upby 47.3%. Significant Growth and Core IP Direction KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW). On PC platforms, PUBG: BATTLEGROUNDS’ diversified content and strong live-service operations contributed significantly to growth while the successful launch of a new IP, inZOI, also p
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform29.4.2025 09:00:00 CEST | Press release
Industry veteran Robert J. Dempsey Appointed Chairman of the Board to Guide Strategic Growth in Europe and the U.S. Azalea (A-zuh-lay-ah)Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appointment of Robert J. Dempsey as Chairman of the Board to guide strategic growth in the European and U.S. markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429247873/en/ Robert Dempsey, Chairman of the Board, Azalea Vision "Strong participation from repeat investors in this Series A milestone reaffirms their trust in our medical device and innovation for the future of intelligent ocular health,” said Enrique Vega, CEO of Azalea Vision. “Additional funding in this round from SPRIM Global Investments and Afrimobility, along with a strategic investor who remains undisclosed, further emphasizes the confidence in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom